Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $588.9M |
| Sales growthchange from the year before | +4.8% |
| Operating marginshare of sales left after running the business | 10.1% |
| Net marginshare of sales kept as profit | 3.0% |
| Free-cash-flow marginspare cash generated per $100 of sales | 18.5% |
| Return on invested capitalprofit made on each $100 put into the business | 3.8% |
| Return on equityprofit vs. shareholders' accounting value | 2.5% |
| Debt / equitydebt vs. shareholders' accounting value | 0.73 |
| Change in share countnegative = the company is buying back its shares | -0.5% |
2 insiders sold $1.0M (all under pre-arranged plans) on the open market.
| Feierstein Matthew DavidPresident | Sold (plan)Aug 5 | 10,000 shat $11.83 · $118K |
| Remer Eric RichardChief Executive Officer · Director | Sold (plan)Aug 5 | 5,757 shat $11.83 · $68K |
| Feierstein Matthew DavidPresident | Sold (plan)Aug 4 | 10,000 shat $11.86 · $119K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy